Huntington National Bank’s Marker Therapeutics MRKR Stock Holding History

Huntington National Bank’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70	Closed	-$385	–	4005
2023 Q4	$385	Hold	70	–	–	﹤0.01%	2304
2023 Q3	$318	Hold	70	–	–	﹤0.01%	2293
2023 Q2	$217	Hold	70	–	–	﹤0.01%	2297
2023 Q1	$50	Hold	70	–	–	﹤0.01%	2481
2022 Q4	$186	Hold	70	–	–	﹤0.01%	2002
2022 Q3	$0	Hold	70	–	–	﹤0.01%	2248
2022 Q2	$0	Hold	70	–	–	﹤0.01%	2269
2022 Q1	$1K	Hold	70	–	–	﹤0.01%	1975
2021 Q4	$0	Hold	70	–	–	﹤0.01%	2188
2021 Q3	$1K	Hold	70	–	–	﹤0.01%	1738
2021 Q2	$2K	Hold	70	–	–	﹤0.01%	1659
2021 Q1	$2K	Hold	70	–	–	﹤0.01%	1552
2020 Q4	$1K	Hold	70	–	–	﹤0.01%	1534
2020 Q3	$1K	Hold	70	–	–	﹤0.01%	1484
2020 Q2	$1K	Hold	70	–	–	﹤0.01%	1462
2020 Q1	$1K	Buy	70 +20	+40%	+$510	﹤0.01%	1483
2019 Q4	$1K	Hold	50	–	–	﹤0.01%	1610
2019 Q3	$3K	Hold	50	–	–	﹤0.01%	1429
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	1449
2019 Q1	$3K	Hold	50	–	–	﹤0.01%	1456
2018 Q4	$3K	Hold	50	–	–	﹤0.01%	1523
2018 Q3	$5K	Hold	50	–	–	﹤0.01%	1507
2018 Q2	$5K	Hold	50	–	–	﹤0.01%	1445
2018 Q1	$2K	Buy	+50	New	+$1.77K	﹤0.01%	1513

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Huntington National Bank's MRKR Position: Q1 2024 in Review

Huntington National Bank sold out of Marker Therapeutics (MRKR) in Q1 2024, closing a stake of 70 shares — an estimated $385 sold.

Huntington National Bank first reported a position in MRKR in Q1 2018 and held it in 24 quarters. The position peaked at $5K in Q3 2018. 28 funds tracked by Wall St. Rank hold MRKR as of Q1 2024.

Huntington National Bank reported no remaining Marker Therapeutics position as of Q1 2024 after selling out during the quarter.
Huntington National Bank sold 70 Marker Therapeutics shares in Q1 2024, an estimated $385.
Huntington National Bank first reported a position in Marker Therapeutics in Q1 2018 and held it in 24 quarters.
Huntington National Bank's Marker Therapeutics position peaked at $5K in Q3 2018.
28 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2024.

Based on Huntington National Bank's 13F filing for Q1 2024, filed 3 May 2024.